Kaplan–Meier curve analysis for lung cancer survival revealed that high IRF9 expression levels were found to be associated with lower overall survival in patients with lung cancer (HR = 1.21, p = 0.0031) and LUAD patients (HR = 1.82, p < 0.001) (Figure 1f,g). This evidence concerns the gene IRF9 and lung carcinoma.